Literature DB >> 21079904

[Complications due to contrast agent administration: what has been confirmed in prevention?].

E Schönenberger1, M Mühler, M Dewey.   

Abstract

Computed tomography (CT) and magnetic resonance imaging (MRI) have been evaluated by internists to be the most important medical innovations. Often, intravenous contrast agent administration is required for answering the clinical questions to CT and MRI. In this review we present an overview of the most common and most important aspects that need to be considered prior to intravenous contrast agent administration. We discuss aspects of renal impairment (contrast-induced nephropathy, nephrogenic systemic fibrosis), allergy-like reactions, hyperthyroidism, and pregnancy and breast-feeding.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21079904     DOI: 10.1007/s00108-010-2760-9

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  40 in total

Review 1.  High-risk situations and procedures.

Authors:  Christoph R Becker; Charles Davidson; Norbert Lameire; Peter A McCullough; Fulvio Stacul; James Tumlin; Andy Adam
Journal:  Am J Cardiol       Date:  2006-02-20       Impact factor: 2.778

Review 2.  Adverse reactions to intravenous iodinated contrast media: a primer for radiologists.

Authors:  Saravanan Namasivayam; Mannudeep K Kalra; William E Torres; William C Small
Journal:  Emerg Radiol       Date:  2006-05-11

3.  CT pulmonary angiography versus ventilation-perfusion scintigraphy in pregnancy: implications from a UK survey of doctors' knowledge of radiation exposure.

Authors:  Ashley M Groves; Stuart J Yates; Thida Win; Irfan Kayani; Ferdia A Gallagher; Rizwan Syed; Jamshed Bomanji; Peter J Ell
Journal:  Radiology       Date:  2006-09       Impact factor: 11.105

4.  Physicians' views of the relative importance of thirty medical innovations.

Authors:  V R Fuchs; H C Sox
Journal:  Health Aff (Millwood)       Date:  2001 Sep-Oct       Impact factor: 6.301

5.  Acute kidney injury, mortality, length of stay, and costs in hospitalized patients.

Authors:  Glenn M Chertow; Elisabeth Burdick; Melissa Honour; Joseph V Bonventre; David W Bates
Journal:  J Am Soc Nephrol       Date:  2005-09-21       Impact factor: 10.121

6.  Quantitative analysis of gadopentetate dimeglumine excreted in breast milk.

Authors:  N M Rofsky; J C Weinreb; A W Litt
Journal:  J Magn Reson Imaging       Date:  1993 Jan-Feb       Impact factor: 4.813

7.  [Prevalence of latent and manifest hyperthyroidism in an iodine-deficient area: non-selected patient population admitted for CT studies with iodine-containing contrast agents].

Authors:  T Saam; T Hess; C Kasperk; G W Kauffmann; M Düx
Journal:  Rofo       Date:  2005-09

8.  Optimal timing of hydration to erase contrast-associated nephropathy: the OTHER CAN study.

Authors:  Richard A Krasuski; Brian M Beard; Jay D Geoghagan; Christopher M Thompson; Stephen A Guidera
Journal:  J Invasive Cardiol       Date:  2003-12       Impact factor: 2.022

9.  Safety and cost effectiveness of high-osmolality as compared with low-osmolality contrast material in patients undergoing cardiac angiography.

Authors:  E P Steinberg; R D Moore; N R Powe; R Gopalan; A J Davidoff; M Litt; S Graziano; J A Brinker
Journal:  N Engl J Med       Date:  1992-02-13       Impact factor: 91.245

10.  The prevention of radiocontrast-agent-induced nephropathy by hemofiltration.

Authors:  Giancarlo Marenzi; Ivana Marana; Gianfranco Lauri; Emilio Assanelli; Marco Grazi; Jeness Campodonico; Daniela Trabattoni; Franco Fabbiocchi; Piero Montorsi; Antonio L Bartorelli
Journal:  N Engl J Med       Date:  2003-10-02       Impact factor: 91.245

View more
  2 in total

1.  [Drug therapy in interventional radiology].

Authors:  M Sumkauskaite; M Bryant; N Kortes; U Stampfl; B Radeleff
Journal:  Radiologe       Date:  2015-06       Impact factor: 0.635

2.  Delayed cardiac tamponade after open heart surgery - is supplemental CT imaging reasonable?

Authors:  Bernhard Floerchinger; Daniele Camboni; Simon Schopka; Philipp Kolat; Michael Hilker; Christof Schmid
Journal:  J Cardiothorac Surg       Date:  2013-06-24       Impact factor: 1.637

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.